AJANTPHARM
1129.1
2019-01-04
AJANTA PHARMA LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.7914 0.8627
Current ratio 2.66 2.73
WC days 124.46 124.9
EBITDA (%) 33.86 31.92
FCF (Rs Cr.) 17.5 24
ROCE (%) 29.13 30.43
ROE (%) 22.13 22.94

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.1 0.22
Div. payout (%) 0 0
Int. Coverage 2344.5 0
LT D/E 0 0
Solvency Ratio 101.14 83.41

Valuation STANDALONE CONSOLIDATED
Beta 1.188 1.188
Div. yield (%) 0 0
EV (Rs Cr.) 12395.6 12342.2
P/BV 6.44 6.1
P/E 29.08 26.57
PEG 1.48 1.18
P/S 6.79 5.84

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 218.37 230.64
3Y growth BV/s (%) 144 141
Cash (Rs Cr.) 38.67 93.09
Total Debt (Rs Cr.) 0 1
Net block (Rs Cr.) 1036.69 1052

P&L metrics STANDALONE CONSOLIDATED
DPS 0 0
EPS 48.33 52.91
Net Income (Rs Cr.) 427.52 468
Operating profit (Rs Cr.) 546.81 658
No. of o/s shares 8.845 8.845
Revenue (Rs Cr.) 1830.45 2130
Total Income (Rs Cr.) 1903.46 2154

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 2478 3222
3Y growth CEPS -0.17 0.01
CFF (Rs Cr.) -0.54 0
CFI (Rs Cr.) -201.12 -260
CFO (Rs Cr.) 219.16 285
FCF (Rs Cr.) 17.5 24
3Y growth Op. CF (%) -17 2

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) -100 -100
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) 24 32
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) 39 50
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) 40 51
1Y growth Op. CF (%) -59 -53
1Q growth revenue (%) 0 0
3Y growth revenue (%) 35 44
4Q growth revenue (%) 0 0